Next Article 
Molecular and Cellular Biology, March 2006, p. 2019-2028, Vol. 26, No. 6
0270-7306/06/$08.00+0 doi:10.1128/MCB.26.6.2019-2028.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Histone Deacetylase Inhibitors Induce VHL and Ubiquitin-Independent Proteasomal Degradation of Hypoxia-Inducible Factor 1
Xianguo Kong,
Zhao Lin,
Dongming Liang,
Donna Fath,
Nianli Sang,* and
Jaime Caro*
Cardeza Foundation for Hematologic Research and Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107
Received 3 September 2005/
Returned for modification 1 November 2005/
Accepted 4 January 2006
Adaptation to hypoxic microenvironment is critical for tumor survival and metastatic spread. Hypoxia-inducible factor 1
(HIF-1
) plays a key role in this adaptation by stimulating the production of proangiogenic factors and inducing enzymes necessary for anaerobic metabolism. Histone deacetylase inhibitors (HDACIs) produce a marked inhibition of HIF-1
expression and are currently in clinical trials partly based on their potent antiangiogenic effects. Although it has been postulated that HDACIs affect HIF-1
expression by enhancing its interactions with VHL (von Hippel Lindau), thus promoting its ubiquitination and degradation, the actual mechanisms by which HDACIs decrease HIF-1
levels are not clear. Here, we present data indicating that HDACIs induce the proteasomal degradation of HIF-1
by a mechanism that is independent of VHL and p53 and does not require the ubiquitin system. This degradation pathway involves the enhanced interaction of HIF-1
with HSP70 and is secondary to a disruption of the HSP70/HSP90 axis function that appears mediated by the activity of HDAC-6.
* Corresponding author. Mailing address for Jaime Caro: 1015 Walnut St., Room 807, Philadelphia, PA 19107. Phone: (215) 955-7775. Fax: (215) 923-3836. E-mail:
jaime.caro{at}jefferson.edu. Mailing address for Nianli Sang: 1015 Walnut St., Room 711, Philadelphia, PA 19107. Phone: (215) 955-5118. Fax: (215) 955-2366. E-mail:
Nianli.sang{at}jefferson.edu.
Molecular and Cellular Biology, March 2006, p. 2019-2028, Vol. 26, No. 6
0022-538X/06/$08.00+0 doi:10.1128/MCB.26.6.2019-2028.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Bhalla, K. N.
(2009). Combined Therapy with Agents Targeted against Deregulated Epigenetic Mechanisms in Cancer. aacredbook
2009: 233-236
[Full Text]
-
Zhou, J., Vos, C. C., Gjyrezi, A., Yoshida, M., Khuri, F. R., Tamanoi, F., Giannakakou, P.
(2009). The Protein Farnesyltransferase Regulates HDAC6 Activity in a Microtubule-dependent Manner. J. Biol. Chem.
284: 9648-9655
[Abstract]
[Full Text]
-
Harten, S. K., Shukla, D., Barod, R., Hergovich, A., Balda, M. S., Matter, K., Esteban, M. A., Maxwell, P. H.
(2009). Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin. Mol. Biol. Cell
20: 1089-1101
[Abstract]
[Full Text]
-
Chamberlain, K. L., Marshall, R. S., Jolliffe, N. A., Frigerio, L., Ceriotti, A., Lord, J. M., Roberts, L. M.
(2008). Ricin B Chain Targeted to the Endoplasmic Reticulum of Tobacco Protoplasts Is Degraded by a CDC48- and Vacuole-independent Mechanism. J. Biol. Chem.
283: 33276-33286
[Abstract]
[Full Text]
-
Granger, A., Abdullah, I., Huebner, F., Stout, A., Wang, T., Huebner, T., Epstein, J. A., Gruber, P. J.
(2008). Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice. FASEB J.
22: 3549-3560
[Abstract]
[Full Text]
-
Zhou, Q., Agoston, A. T., Atadja, P., Nelson, W. G., Davidson, N. E.
(2008). Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells. Mol Cancer Res
6: 873-883
[Abstract]
[Full Text]
-
Lin, X., David, C. A., Donnelly, J. B., Michaelides, M., Chandel, N. S., Huang, X., Warrior, U., Weinberg, F., Tormos, K. V., Fesik, S. W., Shen, Y.
(2008). A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc. Natl. Acad. Sci. USA
105: 174-179
[Abstract]
[Full Text]
-
Rapisarda, A., Melillo, G.
(2008). HIF-1 Inhibitors: Novel Opportunities for Cancer Therapy. Am Soc Clin Oncol Ed Book
2008: 543-547
[Abstract]
[Full Text]
-
Turcotte, S., Giaccia, A. J.
(2008). Targeted Therapy for the Loss of the Tumor Suppressor Gene von Hippel-Lindau through Synthetic Lethality. Am Soc Clin Oncol Ed Book
2008: e15-e18
[Abstract]
[Full Text]
-
Baek, J. H., Liu, Y. V., McDonald, K. R., Wesley, J. B., Zhang, H., Semenza, G. L.
(2007). Spermidine/Spermine N1-Acetyltransferase-1 Binds to Hypoxia-inducible Factor-1{alpha} (HIF-1{alpha}) and RACK1 and Promotes Ubiquitination and Degradation of HIF-1{alpha}. J. Biol. Chem.
282: 33358-33366
[Abstract]
[Full Text]
-
De los Santos, M., Zambrano, A., Sanchez-Pacheco, A., Aranda, A.
(2007). Histone Deacetylase Inhibitors Regulate Retinoic Acid Receptor {beta} Expression in Neuroblastoma Cells by Both Transcriptional and Posttranscriptional Mechanisms. Mol. Endocrinol.
21: 2416-2426
[Abstract]
[Full Text]
-
Oda, T., Hayano, T., Miyaso, H., Takahashi, N., Yamashita, T.
(2007). Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood
109: 5016-5026
[Abstract]
[Full Text]
-
Kong, X., Alvarez-Castelao, B., Lin, Z., Castano, J. G., Caro, J.
(2007). Constitutive/Hypoxic Degradation of HIF-{alpha} Proteins by the Proteasome Is Independent of von Hippel Lindau Protein Ubiquitylation and the Transactivation Activity of the Protein. J. Biol. Chem.
282: 15498-15505
[Abstract]
[Full Text]
-
Melillo, G.
(2006). Inhibiting Hypoxia-Inducible Factor 1 for Cancer Therapy. Mol Cancer Res
4: 601-605
[Abstract]
[Full Text]
-
Fath, D. M., Kong, X., Liang, D., Lin, Z., Chou, A., Jiang, Y., Fang, J., Caro, J., Sang, N.
(2006). Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-{alpha}. J. Biol. Chem.
281: 13612-13619
[Abstract]
[Full Text]